Physician profile
Michael David Mazer
NPI 1104352707
$12,436.11
in general payments reported to CMS, 2019-2025
23 companies · $2,232 in 2025
The $2,232 reported for 2025 was more than what 85% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.57 · 2020: $259 · 2021: $2,610 · 2022: $2,013 · 2023: $2,470 · 2024: $2,820 · 2025: $2,232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,050 · Travel and Lodging: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,049.69 |
| Travel and Lodging | $472.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $3,646.01 | 2020-2022 | |
| Stryker Corporation | $2,798.22 | 2020-2025 | Citrefix, Augment Injectable, 7 X 23mm Citrelock Implant |
| Kerecis Limited | $1,681.87 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Smith+Nephew, INC. | $816.23 | 2020-2025 | Oasis, Grafix, Grafix Pl |
| Acumed LLC | $694.10 | 2023 | Acumed, Osteomed |
| Inari Medical, INC. | $573.15 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Treace Medical Concepts, INC. | $546.48 | 2024-2025 | |
| Paragon 28, INC. | $333.79 | 2021-2025 | Portfolio, Precision Mis Bunion |
| Paratek Pharmaceuticals, INC. | $265.55 | 2021-2025 | Nuzyra |
| Tactile Systems Technology INC | $166.01 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $148.65 | 2023 | Jublia |
| Solventum Corporation | $125.71 | 2024 | V.A.C. Veraflo, Prevena, V.A.C. Dermatac |
| Amgen INC. | $125.00 | 2025 | Krystexxa |
| Averitas Pharma INC. | $122.19 | 2024 | Qutenza |
| Abbvie INC. | $121.81 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocomposites INC | $100.00 | 2025 | Stimulan |
| Osteomed LLC | $32.57 | 2019 | |
| Organogenesis INC. | $27.00 | 2023 | Puraply |
| Suvon Surgical LLC | $26.87 | 2024 | |
| Baxter Healthcare | $26.18 | 2022 | |
| Misonix INC | $21.08 | 2020 | |
| Medtronic Vascular, INC. | $19.00 | 2020 | |
| Polaris Technology Solutions LLC | $18.64 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.